Concepedia

Huaqiang Xie

HX

Statistics

Publications

3

Citations

71

H-Index

3

Active since

2019

Affiliations

Hubei University of Medicine(Current)

Taihe Hospital

Huaqiang Xie is an author at Hubei University of Medicine specializing in atherosclerosis risk, atherosclerosis molecular mechanisms, and inflammation.

Publications per year

2019–2022

3

Publications

3

Empagliflozin inhibits macrophage inflammation through AMPK signaling pathway and plays an anti-atherosclerosis role

Jie Fu, Hualin Xu, Fuyun Wu et al. · International Journal of Cardiology · 2022 · 41 citations

, , +14

Down-regulated of SREBP-1 in circulating leukocyte is a risk factor for atherosclerosis: a case control study

Chunyan Peng, Lei Pan, Xiandong Li et al. · Lipids in Health and Disease · 2019 · 19 citations · Full text

, , +13

Up-regulation of GLP-1R improved the dysfunction of late EPCs under hyperglycemia by regulating SIRT1 expression

Qiang Tu, Junfeng Wang, Huaqiang Xie et al. · Molecular and Cellular Endocrinology · 2021 · 11 citations · Full text

, , +17

1–3 of 3